Analysts expect Lakefront Biotherapeutics NV to report revenue of 7.27 M for Q3 26, against a range of 6.76 M to 7.77 M. The most recent reported quarter, Q2 26, came in at 13.99 M, a 138.5% beat against the 5.87 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 64.98 M | 79.31 M | 85.28 M | 76.82 M | 82.12 M | 1.05 B | 7.63 M | 13.99 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 76.03 M | 75.58 M | 73.88 M | 89.76 M | 89.16 M | 95.68 M | 9.85 M | 6.10 M | 7.77 M | 7.85 M | 8.93 M | 8.08 M | 7.54 M | 29.71 M | 4.83 M | 3.55 M | ||||||||||
| Low Estimate | 69.14 M | 70.19 M | 61.40 M | 75.11 M | 73.25 M | 79.88 M | 8.37 M | 5.63 M | 6.76 M | 7.31 M | 8.12 M | 7.03 M | 6.35 M | 25.37 M | 4.47 M | 3.28 M | ||||||||||
| Consensus Estimate | 72.58 M | 72.89 M | 67.64 M | 82.43 M | 81.21 M | 87.78 M | 9.11 M | 5.87 M | 7.27 M | 7.58 M | 8.53 M | 7.56 M | 6.95 M | 27.54 M | 4.65 M | 3.41 M |
Analysts expect Lakefront Biotherapeutics NV to report earnings per share of -0.81 for Q3 26, against a range of -0.86 to -0.76. The most recent reported quarter, Q2 26, came in at 0.03, a 103.5% beat against the -0.86 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.80 | 0.30 | -2.67 | -1.85 | -3.54 | 13.90 | 0.25 | 0.03 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.15 | -0.49 | -0.14 | -0.23 | -0.46 | -0.12 | -0.96 | -0.82 | -0.76 | -1.19 | -0.47 | -0.46 | -1.08 | 1.09 | -1.95 | -1.03 | ||||||||||
| Low Estimate | -0.17 | -0.53 | -0.16 | -0.25 | -0.54 | -0.14 | -1.04 | -0.90 | -0.86 | -1.37 | -0.53 | -0.52 | -1.22 | 0.97 | -2.27 | -1.21 | ||||||||||
| Consensus Estimate | -0.16 | -0.51 | -0.15 | -0.24 | -0.50 | -0.13 | -1.00 | -0.86 | -0.81 | -1.28 | -0.50 | -0.49 | -1.15 | 1.03 | -2.11 | -1.12 |
Pull Wall Street consensus for Lakefront Biotherapeutics NV (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=LKFT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "LKFT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=LKFT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();